Six versus three-weekly pembrolizumab: as well-tolerated?. (June 2021)
- Record Type:
- Journal Article
- Title:
- Six versus three-weekly pembrolizumab: as well-tolerated?. (June 2021)
- Main Title:
- Six versus three-weekly pembrolizumab: as well-tolerated?
- Authors:
- Williams, Fiona
John, Rebecca
Davies, Rhian
Brewster, Alison
Edwards, Bleddyn
Davies, Mari
Lester, Jason - Abstract:
- Is Part Of:
- Lung cancer. Volume 156(2021)Supplement 1
- Journal:
- Lung cancer
- Issue:
- Volume 156(2021)Supplement 1
- Issue Display:
- Volume 156, Issue 1 (2021)
- Year:
- 2021
- Volume:
- 156
- Issue:
- 1
- Issue Sort Value:
- 2021-0156-0001-0000
- Page Start:
- S11
- Page End:
- S12
- Publication Date:
- 2021-06
- Subjects:
- Lungs -- Cancer -- Periodicals
Lung Neoplasms -- Abstracts
Lung Neoplasms -- Periodicals
Poumons -- Cancer -- Périodiques
Lungs -- Cancer
Periodicals
Electronic journals
Electronic journals
616.99424 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01695002 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01695002 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01695002 ↗
http://www.lungcancerjournal.info/issues ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S0169-5002(21)00227-0 ↗
- Languages:
- English
- ISSNs:
- 0169-5002
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5307.245000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18358.xml